In skeletal muscle, GSK3 disrupts glucose metabolism through interference with insulin signaling and the inhibition of glycogen synthesis, contributing to muscle insulin resistance and impaired glucose utilization in obesity. The gene discussed is INS; the disease is obesity disorder.